Margaret A. Alexander sold $2,956 of OVID
President and COO at Ovid Therapeutics Inc.. 5,279 shares at an average of $0.56, traded Feb 26, 2025, filed Feb 28, 2025.
Score components
- +20RolePresident
- 0Trade size$3k at market
- 0Share of holdings soldSold 6.7% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-005998, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 26, 2025 | SOpen-market sale Common Stock | -5,279 | $0.56 | $2,956 | 73,406 | Feb 28, 2025 |
Related signals
Other insiders at Ovid Therapeutics Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 26Weak | OVIDbuy Ovid Therapeutics Inc. | Margaret A. Alexander President and COO | $4,971 6,810 shares | +24% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.